QUIDELORTHO CORP Derivative Asset
QUIDELORTHO CORP (QDEL) had Derivative Asset of $20.50 million as of 2025-09-28, per its 10-Q filed 2025-11-06.
Financial Statements › Balance Sheet › Assets
us-gaap:DerivativeAssets · last filed 2025-11-06
- 2025-09-28: Derivative Asset $20.50M.
- 2025-06-29: Derivative Asset $28.10M.
- 2025-03-30: Derivative Asset $15.20M.
- 2024-12-29: Derivative Asset $36.60M.
| Period end | Derivative Asset |
|---|---|
| 2025-09-28 | $20.50M 10-Q · filed 2025-11-06 |
| 2025-06-29 | $28.10M 10-Q · filed 2025-08-06 |
| 2025-03-30 | $15.20M 10-Q · filed 2025-05-08 |
| 2024-12-29 | $36.60M 10-Q · filed 2025-11-06 |
| 2024-09-29 | $10.30M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $42.20M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $29.50M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $6.90M 10-K · filed 2025-02-27 |
| 2023-10-01 | $49.90M 10-Q · filed 2023-11-02 |
| 2023-07-02 | $32.60M 10-Q · filed 2023-08-09 |
| 2023-04-02 | $17.10M 10-Q · filed 2023-05-04 |
| 2023-01-01 | $22.00M 10-K/A · filed 2024-08-01 |
| 2022-01-02 | $100.00K 10-K · filed 2023-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |